Pyc.asx

Financial Times Close.

Looks you are already a member. Please enter your password to proceed. Forgotten password? Click here. Please make sure your payment details are up to date to continue your membership. Please contact Member Services on support investsmart.

Pyc.asx

Driven to transform the lives of patients through a new generation of RNA therapeutics. PYC Therapeutics combines world-leading RNA therapeutic drug design with a revolutionary delivery technology based on a proprietary library of naturally derived Cell Penetrating Peptides CPPs to solve the delivery challenge associated with traditional RNA therapeutics. PYC has a initial focus on ophthalmology, neurodevelopmental and kidney diseases and aims to apply its platform technology to further indications. Our Platform is highly versatile and modular, offering broad potential across therapeutic areas. PYC's goal is to provide patients with no current treatment options a therapeutic that addresses the underlying cause of the disease. Truly Life-Changing Science. Latest Announcements. View all. We discover and develop RNA therapies to change the lives of patients with genetic diseases. Our Science. Disease areas PYC has a initial focus on ophthalmology, neurodevelopmental and kidney diseases and aims to apply its platform technology to further indications. Life-Changing Science PYC's goal is to provide patients with no current treatment options a therapeutic that addresses the underlying cause of the disease. Stay Connected.

High number of new and inexperienced directors Nov PYC's goal is to provide patients with no current pyc.asx options a therapeutic that addresses the underlying cause of the disease, pyc.asx.

PYC Therapeutics Limited. PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of RNA therapeutics in Australia. About the company. It also focuses on the development of programs for kidney, neurodevelopmental, retinal, and central nervous system diseases. Revenue is forecast to grow

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board. Corporate governance. Media centre. ASX rulebooks.

Pyc.asx

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company, which offers ribonucleic acid RNA therapeutics in patients with unmeet genetic diseases. The Company develops a pi peline of therapies, including two programs, which are focused on inherited eye diseases and preclinical discovery programs, which are focused on neurodegenerative and kidney diseases. Its preclinical, clinical, regulatory and corporate operations are based in San Diego, California. The Company's discovery and laboratory operations are located in Australia. Financial Times Close. Search the FT Search.

Chie filomeno

Intelligent Investor Membership. Driven to transform the lives of patients through a new generation of RNA therapeutics. Investment tools and resources. Life-Changing Science PYC's goal is to provide patients with no current treatment options a therapeutic that addresses the underlying cause of the disease. See more updates Recent updates. Join Intelligent Investor today. Updating information Please wait Please make sure your payment details are up to date to continue your membership. Mar Email must be a valid email. ASX Compliance.

PYC Therapeutics Limited.

Show more Companies link Companies. Verification code is required. Call Sign up. Investment options. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Having trouble renewing? Price AUD 0. ASX regulatory framework. Please check your inbox.